Efficacy of vitamin D replacement therapy on 28 cases of myalgic encephalomyelitis/chronic fatigue syndrome after COVID-19 vaccination
For patients developing ME/CFS after COVID-19 vaccination with insufficient or deficient vitamin D levels, appropriate vitamin D replacement therapy under medical guidance may lead to symptomatic relief. We are preparing a randomized controlled trial to evaluate the efficacy of vitamin D replacement therapy in individuals with ME/CFS who have developed vitamin D deficiency following COVID-19 infection or vaccination.
Authors
- Shohta Kodama
- Nafuko Konishi
- Satoshi Teramukai (ORCID: https://orcid.org/0000-0003-2184-0597)
- Akinori Fujisawa
- Masanori Fukushima (ORCID: https://orcid.org/0000-0001-8594-0066)
- Mitsuko Nakata (ORCID: https://orcid.org/0000-0003-2401-0628)
- Yuriko Hirai
Institutions
- Hokkaido Information University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Mitsubishi Corporation (Japan) (JP)
- Osaka Nishi Clinic (JP)
- Shinko Hospital (JP)
Publication Details
- Journal
- Nutrition
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1016/j.nut.2025.112718
- Citations
- 3
- Primary Topic
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Type
- article
- Field-Weighted Citation Impact
- 4.41